1. Home
  2. OHI vs BIO Comparison

OHI vs BIO Comparison

Compare OHI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OHI
  • BIO
  • Stock Information
  • Founded
  • OHI 1992
  • BIO 1952
  • Country
  • OHI United States
  • BIO United States
  • Employees
  • OHI N/A
  • BIO N/A
  • Industry
  • OHI Real Estate Investment Trusts
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • OHI Real Estate
  • BIO Industrials
  • Exchange
  • OHI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • OHI 10.1B
  • BIO 9.2B
  • IPO Year
  • OHI N/A
  • BIO N/A
  • Fundamental
  • Price
  • OHI $36.77
  • BIO $245.33
  • Analyst Decision
  • OHI Buy
  • BIO Strong Buy
  • Analyst Count
  • OHI 10
  • BIO 4
  • Target Price
  • OHI $40.78
  • BIO $415.25
  • AVG Volume (30 Days)
  • OHI 2.1M
  • BIO 390.5K
  • Earning Date
  • OHI 05-01-2025
  • BIO 05-06-2025
  • Dividend Yield
  • OHI 7.29%
  • BIO N/A
  • EPS Growth
  • OHI 55.44
  • BIO N/A
  • EPS
  • OHI 1.55
  • BIO N/A
  • Revenue
  • OHI $1,051,390,000.00
  • BIO $2,566,500,000.00
  • Revenue This Year
  • OHI N/A
  • BIO $1.11
  • Revenue Next Year
  • OHI $5.38
  • BIO $4.55
  • P/E Ratio
  • OHI $23.76
  • BIO N/A
  • Revenue Growth
  • OHI 10.70
  • BIO N/A
  • 52 Week Low
  • OHI $29.66
  • BIO $244.00
  • 52 Week High
  • OHI $44.42
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • OHI 48.93
  • BIO 25.93
  • Support Level
  • OHI $35.91
  • BIO $244.19
  • Resistance Level
  • OHI $38.14
  • BIO $258.82
  • Average True Range (ATR)
  • OHI 0.96
  • BIO 9.73
  • MACD
  • OHI 0.04
  • BIO 0.04
  • Stochastic Oscillator
  • OHI 48.11
  • BIO 3.35

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: